VOLITIONRX LTD — Director's Dealing 2014

Dec 17, 2014

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2014-07-01

Reporting Person: O'Connell Michael James (Chief Financial Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	0	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Option	$3	2018-02-18	Common Stock (10000)		Direct
Option	$3	2018-08-18	Common Stock (10000)		Direct
Option	$4	2019-02-18	Common Stock (10000)		Direct
Option	$4	2019-08-18	Common Stock (10000)		Direct
Option	$5	2020-02-18	Common Stock (10000)		Direct
Option	$5	2020-08-18	Common Stock (10000)		Direct

Footnotes

F1: On July 1, 2014, Mr. Mike O'Connell was appointed to serve as the Company's Chief Financial Officer.

F2: On August 18, 2014, the Company granted to Mr. O'Connell (the "Optionee") a total of 60,000 options pursuant to the Company's Equity Incentive Plan. Of the 60,000 total options granted, 1/6th or 10,000 shares vest every six months after the grant date, subject to the Optionee's continued service as of the vesting date(s).